Canadian startup Deep Genomics scored $180 million in Series C funding for its artificial intelligence technology designed to help program and prioritize transformational RNA therapeutics for genetic diseases.
The round was led by SoftBank Vision Fund 2* with participation from Canadian Pension Plan Investment Board (CPP Investments), Fidelity Management & Research Company LLC, Alexandria...
